Literature DB >> 12699851

Prevalence and characterization of hepatitis C virus genotype 4 in Japanese hepatitis C carriers.

Kazuhiko Hayashi1, Yoshihide Fukuda, Isao Nakano, Yoshiaki Katano, Hidenori Toyoda, Shouichi Yokozaki, Tetsuo Hayakawa, Kiyoshi Morita, Daisaku Nishimura, Katsumoto Kato, Fumihiro Urano, Junki Takamatsu.   

Abstract

Hepatitis C virus (HCV) can be classified into six major genotypes, the prevalences of which differ around the world. In Japan, the main genotypes are HCV 1 and HCV 2; others are found only rarely. Little is known about the prevalence in Japan of HCV genotype 4 which, is found frequently in North and Central Africa and the Middle East. Thus, we conducted a study to clarify distribution of HCV genotype 4 and the clinical demographics of patients with HCV genotype 4 in Japan. We examined HCV genotypes in 899 Japanese individuals with HCV viremia living in Aichi Prefecture, including 63 hemophiliacs. Four patients (0.4%) were infected with HCV genotype 4. All four of these patients were male hemophiliacs who had received clotting factors from foreign countries. Three patients were co-infected with human immunodeficiency virus (HIV); none were co-infected with GB virus-C/hepatitis G virus. Phylogenetic analysis of the El region indicated that all four patients were infected with subtype 4a. This subtype is related genetically to a subtype previously reported in Japanese and Italian hemophiliacs. HCV genotype 4 is indeed rare in Japan and may be detected only among hemophiliacs who have received inactivated clotting factor concentrates from foreign countries.

Entities:  

Year:  2003        PMID: 12699851     DOI: 10.1016/s1386-6346(03)00016-0

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  3 in total

1.  Association of ITPA polymorphism with outcomes of peginterferon-α plus ribavirin combination therapy.

Authors:  Tatsuya Fujino; Yoko Aoyagi; Mariko Takahashi; Ryoko Yada; Naoko Yamamoto; Yuki Ohishi; Akihiko Nishiura; Motoyuki Kohjima; Tsuyoshi Yoshimoto; Kunitaka Fukuizumi; Manabu Nakashima; Masaki Kato; Kazuhiro Kotoh; Makoto Nakamuta; Munechika Enjoji
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-08-06

2.  Epidemiological features of patients infected with HCV genotype 4 in Poland: Epidemiology of HCV genotype 4 in Poland.

Authors:  Slawomir Chlabicz; Robert Flisiak; Tadeusz W Lapinski; Oksana Kowalczuk; Alicja Wiercinska-Drapalo; Barbara Pytel-Krolczuk; Anna Grzeszczuk; Lech Chyczewski; Joanna Pancewicz
Journal:  Hepat Mon       Date:  2011-03       Impact factor: 0.660

3.  Integrated Resistance Analysis of CERTAIN-1 and CERTAIN-2 Studies in Hepatitis C Virus-Infected Patients Receiving Glecaprevir and Pibrentasvir in Japan.

Authors:  Preethi Krishnan; Gretja Schnell; Rakesh Tripathi; Jill Beyer; Thomas Reisch; Tatyana Dekhtyar; Michelle Irvin; Wangang Xie; Bo Fu; Margaret Burroughs; Rebecca Redman; Hiromitsu Kumada; Kazuaki Chayama; Christine Collins; Tami Pilot-Matias
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.